Stock Movement in Hong Kong | Baiao Sai Tu-B (02315) Surges Over 5% Again; Strong Growth in Core Business Drives High Revenue; Institutions Remain Bullish on the Company’s Long-Term Growth Potential

BioRay-B (02315) surged over 5% again. As of the time of writing, it rose by 5.41%, trading at HKD 47.96 with a turnover of HKD 69.8685 million.

Zhitong FinanceFeb 4 02:28 ET

ZHITONG HK Stock Connect Proportion Anomaly Statistics | February 4

Intelligent Channel HK Stock Connect Proportion Anomaly Statistics | February 3, 2026

Zhitong FinanceFeb 3 19:36 ET

Hong Kong Stock Market Midday Review | The Hang Seng Index rose 0.20% in the morning session, while internet heavyweights dragged the Hang Seng Tech Index down by 1.32%.

The commercial aerospace sector has rebounded today. SpaceX's acquisition of xAI is aimed at leveraging space computing power, while domestic commercial aerospace companies are accelerating their IPO processes.

Zhitong FinanceFeb 2 23:00 ET

Biocytogen surges as annual net profit is forecasted to increase by up to 4.4 times, with the company having secured multiple significant out-licensing deals.

Biocytogen-B (02315) surged again by over 10%. As of the time of writing, it had risen by 8.58%, trading at HKD 45.56, with a turnover of HKD 66.1952 million.

Zhitong FinanceFeb 2 22:02 ET

Stock Movement | Baiao Sai Tu-B (02315) surged nearly 13% after a positive profit forecast, with expected annual revenue growth of approximately 40% and net profit growth of around 400%.

After issuing a profit alert, Biocytogen-B (02315) surged nearly 13%. As of the time of writing, it was up 8.82%, trading at HKD 47.88 with a turnover of HKD 27.715 million.

Zhitong FinanceJan 29 20:43 ET

Statistical Report on Abnormal Movements in Hong Kong Stock Connect Holdings | January 30

Zhitong HK Stock Connect Proportion Anomaly Statistics | January 29, 2026

Zhitong FinanceJan 29 19:36 ET